Pages

Saturday 22 October 2011

Tenofovir gel reduces risk of genital herpes and HIV, study shows

Call it an antiviral one-two punch. An HIV-fighting drug has been shown to be even more effective against genital herpes when it's applied as a gel, new research shows.

A study released this week by the journal Cell Host & Microbe that tested the gel on women in South Africa (where the risk of HIV and herpes is great) found that the anti-HIV/AIDS drug tenofovir reduced herpes infections by 51% and HIV infections by 39%.   Read Here

No comments:

Post a Comment

free counters

Map